Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
Cash generated from core business operations
| Period | Value | Change |
|---|---|---|
| 2024 | $-492.60M | -113.9% |
| 2023 | $3.54B | -14.3% |
| 2022 | $4.13B | +56.2% |
| 2021 | $2.64B | -18.7% |
| 2020 | $3.25B | +107.3% |
| 2019 | $1.57B | +23.5% |
| 2018 | $1.27B | +50.3% |
| 2017 | $844.94M | +257.9% |
| 2016 | $236.10M | +164.6% |
| 2015 | $-365.43M | - |